Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 17 studies | 35% ± 12% | |
lung | 14 studies | 30% ± 15% | |
intestine | 8 studies | 34% ± 15% | |
kidney | 6 studies | 30% ± 9% | |
liver | 5 studies | 30% ± 18% | |
lymph node | 5 studies | 39% ± 8% | |
bone marrow | 4 studies | 29% ± 6% | |
uterus | 4 studies | 36% ± 16% | |
breast | 4 studies | 27% ± 4% | |
placenta | 3 studies | 31% ± 12% | |
eye | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 9275.86 | 226 / 226 | 100% | 127.60 | 406 / 406 |
ovary | 100% | 14904.50 | 180 / 180 | 100% | 282.90 | 430 / 430 |
pancreas | 100% | 8084.32 | 328 / 328 | 100% | 117.05 | 178 / 178 |
skin | 100% | 11591.53 | 1809 / 1809 | 100% | 198.65 | 472 / 472 |
thymus | 100% | 8589.26 | 653 / 653 | 100% | 144.32 | 604 / 605 |
intestine | 100% | 11366.96 | 966 / 966 | 100% | 196.14 | 526 / 527 |
prostate | 100% | 9209.37 | 245 / 245 | 100% | 183.40 | 501 / 502 |
uterus | 100% | 10832.44 | 170 / 170 | 100% | 170.57 | 458 / 459 |
kidney | 100% | 7682.75 | 89 / 89 | 100% | 143.49 | 899 / 901 |
breast | 100% | 10102.88 | 459 / 459 | 99% | 150.86 | 1112 / 1118 |
esophagus | 100% | 9961.98 | 1445 / 1445 | 99% | 130.00 | 182 / 183 |
stomach | 100% | 8299.61 | 359 / 359 | 99% | 168.81 | 284 / 286 |
bladder | 100% | 9871.62 | 21 / 21 | 99% | 177.57 | 500 / 504 |
adrenal gland | 100% | 11715.22 | 258 / 258 | 99% | 111.44 | 228 / 230 |
brain | 99% | 4367.19 | 2614 / 2642 | 100% | 145.02 | 705 / 705 |
lung | 99% | 7100.65 | 575 / 578 | 99% | 163.38 | 1147 / 1155 |
adipose | 100% | 9883.57 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 255.26 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 228.44 | 29 / 29 |
muscle | 100% | 11093.68 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 8843.48 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 169.53 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 66.65 | 1 / 1 |
blood vessel | 100% | 7750.08 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 6881.09 | 849 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 8399.14 | 900 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_1900208 | Biological process | regulation of cardiolipin metabolic process |
GO_0023035 | Biological process | CD40 signaling pathway |
GO_0060762 | Biological process | regulation of branching involved in mammary gland duct morphogenesis |
GO_0007062 | Biological process | sister chromatid cohesion |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_1902808 | Biological process | positive regulation of cell cycle G1/S phase transition |
GO_0002639 | Biological process | positive regulation of immunoglobulin production |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0030449 | Biological process | regulation of complement activation |
GO_1904959 | Biological process | regulation of cytochrome-c oxidase activity |
GO_0060744 | Biological process | mammary gland branching involved in thelarche |
GO_0033598 | Biological process | mammary gland epithelial cell proliferation |
GO_0060749 | Biological process | mammary gland alveolus development |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0031536 | Biological process | positive regulation of exit from mitosis |
GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
GO_0033147 | Biological process | negative regulation of intracellular estrogen receptor signaling pathway |
GO_0033600 | Biological process | negative regulation of mammary gland epithelial cell proliferation |
GO_0007005 | Biological process | mitochondrion organization |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0050821 | Biological process | protein stabilization |
GO_0042113 | Biological process | B cell activation |
GO_0006606 | Biological process | protein import into nucleus |
GO_0039529 | Biological process | RIG-I signaling pathway |
GO_0000423 | Biological process | mitophagy |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0030520 | Biological process | estrogen receptor signaling pathway |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0016477 | Biological process | cell migration |
GO_1990051 | Biological process | activation of protein kinase C activity |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0140374 | Biological process | antiviral innate immune response |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0016363 | Cellular component | nuclear matrix |
GO_0098982 | Cellular component | GABA-ergic synapse |
GO_0009986 | Cellular component | cell surface |
GO_0048786 | Cellular component | presynaptic active zone |
GO_0071944 | Cellular component | cell periphery |
GO_0035632 | Cellular component | mitochondrial prohibitin complex |
GO_0014069 | Cellular component | postsynaptic density |
GO_0005737 | Cellular component | cytoplasm |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0030424 | Cellular component | axon |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0046625 | Molecular function | sphingolipid binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0030331 | Molecular function | nuclear estrogen receptor binding |
GO_0033218 | Molecular function | amide binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PHB2 |
Protein name | Prohibitin-2 (B-cell receptor-associated protein BAP37) (D-prohibitin) (Repressor of estrogen receptor activity) Prohibitin 2 (Prohibitin-2 variant) Prohibitin |
Synonyms | BAP REA |
Description | FUNCTION: Protein with pleiotropic attributes mediated in a cell-compartment- and tissue-specific manner, which include the plasma membrane-associated cell signaling functions, mitochondrial chaperone, and transcriptional co-regulator of transcription factors and sex steroid hormones in the nucleus. .; FUNCTION: In the mitochondria, together with PHB, forms large ring complexes (prohibitin complexes) in the inner mitochondrial membrane (IMM) and functions as a chaperone protein that stabilizes mitochondrial respiratory enzymes and maintains mitochondrial integrity in the IMM, which is required for mitochondrial morphogenesis, neuronal survival, and normal lifespan (Probable). The prohibitin complex, with DNAJC19, regulates cardiolipin remodeling and the protein turnover of OMA1 in a cardiolipin-binding manner (By similarity). Also regulates cytochrome-c oxidase assembly (COX) and mitochondrial respiration . Binding to sphingoid 1-phosphate (SPP) modulates its regulator activity . Has a key role of mitophagy receptor involved in targeting mitochondria for autophagic degradation . Involved in mitochondrial-mediated antiviral innate immunity, activates RIG-I-mediated signal transduction and production of IFNB1 and pro-inflammatory cytokine IL6 . .; FUNCTION: In the nucleus, serves as transcriptional co-regulator (Probable). Acts as a mediator of transcriptional repression by nuclear hormone receptors via recruitment of histone deacetylases. Functions as an estrogen receptor (ER)-selective coregulator that potentiates the inhibitory activities of antiestrogens and represses the activity of estrogens. Competes with NCOA1 for modulation of ER transcriptional activity (By similarity). .; FUNCTION: In the plasma membrane, is involved in IGFBP6-induced cell migration . Cooperates with CD86 to mediate CD86-signaling in B lymphocytes that regulates the level of IgG1 produced through the activation of distal signaling intermediates. Upon CD40 engagement, required to activate NF-kappa-B signaling pathway via phospholipase C and protein kinase C activation (By similarity). .; FUNCTION: (Microbial infection) Involved in human enterovirus 71/EV-71 infection by enhancing the autophagy mechanism during the infection. . FUNCTION: Protein with pleiotropic attributes mediated in a cell-compartment- and tissue-specific manner, which include the plasma membrane-associated cell signaling functions, mitochondrial chaperone, and transcriptional co-regulator of transcription factors and sex steroid hormones in the nucleus. . FUNCTION: Protein with pleiotropic attributes mediated in a cell-compartment- and tissue-specific manner, which include the plasma membrane-associated cell signaling functions, mitochondrial chaperone, and transcriptional co-regulator of transcription factors and sex steroid hormones in the nucleus. . FUNCTION: Protein with pleiotropic attributes mediated in a cell-compartment- and tissue-specific manner, which include the plasma membrane-associated cell signaling functions, mitochondrial chaperone, and transcriptional co-regulator of transcription factors and sex steroid hormones in the nucleus. . FUNCTION: Protein with pleiotropic attributes mediated in a cell-compartment- and tissue-specific manner, which include the plasma membrane-associated cell signaling functions, mitochondrial chaperone, and transcriptional co-regulator of transcription factors and sex steroid hormones in the nucleus. . FUNCTION: Protein with pleiotropic attributes mediated in a cell-compartment- and tissue-specific manner, which include the plasma membrane-associated cell signaling functions, mitochondrial chaperone, and transcriptional co-regulator of transcription factors and sex steroid hormones in the nucleus. . FUNCTION: Protein with pleiotropic attributes mediated in a cell-compartment- and tissue-specific manner, which include the plasma membrane-associated cell signaling functions, mitochondrial chaperone, and transcriptional co-regulator of transcription factors and sex steroid hormones in the nucleus. . FUNCTION: Protein with pleiotropic attributes mediated in a cell-compartment- and tissue-specific manner, which include the plasma membrane-associated cell signaling functions, mitochondrial chaperone, and transcriptional co-regulator of transcription factors and sex steroid hormones in the nucleus. . FUNCTION: Protein with pleiotropic attributes mediated in a cell-compartment- and tissue-specific manner, which include the plasma membrane-associated cell signaling functions, mitochondrial chaperone, and transcriptional co-regulator of transcription factors and sex steroid hormones in the nucleus. . FUNCTION: Protein with pleiotropic attributes mediated in a cell-compartment- and tissue-specific manner, which include the plasma membrane-associated cell signaling functions, mitochondrial chaperone, and transcriptional co-regulator of transcription factors and sex steroid hormones in the nucleus. . |
Accessions | ENST00000399433.7 ENST00000542912.5 F5H0C5 Q99623 F5H2D2 A0A7I2V5F0 ENST00000545167.5 ENST00000544888.5 ENST00000536316.3 A0A976LZI3 F5H3X6 J3KPX7 ENST00000440277.6 [Q99623-2] ENST00000546111.5 A0A3G2KQ93 ENST00000535923.6 [Q99623-1] U3KPZ5 F5GWA7 ENST00000545555.2 ENST00000678829.1 ENST00000676496.1 F5GY37 |